
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Preclinical Data Supporting TNX-1700 As ...
(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company advancing immunotherapy resistance solutions, announced the publication of new preclinical findings in Cancer Cell showing its fusion protein candidate mTNX …